Hypha Labs

FUNI · OTC

$0.0043+$0.0001 (+2.38%)TodayMarket closed ·
No price history for this range.

About FUNI

Hypha Labs, Inc. engages in the research, development, and commercialization of a bioreactor. The company is headquartered in Las Vegas, Nevada and currently employs 5 full-time employees. The company went IPO on 2011-12-23. The Hypha Micropearl bioreactor is a home appliance designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company’s device, together with its replacement cartridges, produces enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contain active mushroom ingredients that offer a way to harness the medicinal properties of fungi in a concentrated easy to handle tasteless and odorless form. These Micropearls can be incorporated into various food and beverages without altering the flavor. The QR codes on the cartridges are scanned to the Hypha Lab app and inserted into the device and the Micropearls are produced and fully formed in eight days. Its Hypha Micropearl bioreactor is to be sold with replaceable cartridges.

Employees
5
Headquarters
Las Vegas, Nevada
Listed
Dec 23, 2011
Sector
Consumer Discretionary
Industry
Household Durables

Leadership

Hypha Labs executives
NameTitleSince
A. Stone Douglass—2021
Dennis Hartman—2019

Similar companies

Companies in the same industry as Hypha Labs

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.